| 1. |
KLAASSEN C D. Heavy metals and heavymetal antagonists. In: Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics[J]. New York: McGrawHill,1996:1649-1672.
|
| 2. |
KWONG Y L, TODD D. Delicious poison: arsenic trioxide for thetreatment of leukemia[letter][J]. Blood,1997,89:3487-3488.
|
| 3. |
BAJ G, ARNULFO A, DEAGLIO S, et al. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiation and immunomodulatory effects[J]. Breast Cancer Res Treat,2002,73(1):61-73.
|
| 4. |
杜彩文,李德锐,杜英城,等.三氧化二砷诱导人鼻咽低分化鳞癌裸鼠移植瘤细胞分化的研究[J].癌症,2003,22(1):21-25.
|
| 5. |
ZHOU D C, GAO M, FERRARI A C, et al. Arsenic trioxide is an equipotent inducer of apoptosis in androgendependent and androgenindependent LNCaP prostate cancer cell sublines[abstract 3999]. Proc AACR,1998,39:588.
|
| 6. |
ZHENG J (郑杰), DENG Y P, LIN C, et al. Arsenic trioxide induces apoptosis of HPV16 DNAimmortalized human cervical epithelial cells and selectively inhibits viral gene expression[J]. Int Cancer,1999,82:286-292.
|
| 7. |
YANG C H, WANG T Y, CHEN Y C. Cytotoxicity of arsenic trioxide in cancer cell lines[abstract 1552][J]. Proc AACR,1998,39:227.
|
| 8. |
XIAO Y F (肖延风), LIU S X, WU D D, et al. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growthfactor in gastric cancer[J]. World J Gastroenterol,2006,12(36):5780-5786.
|
| 9. |
黄学武,李轶群,黄海福.亚砷酸注射液治疗原发性肝癌的临床疗效观察[J].中药材,2008,31(9):1454-1456.
|
| 10. |
黄苹,陈强,张其忠,等.亚砷酸注射液治疗中晚期原发性肝癌的临床研究[J].中国误诊学杂志,2002,2(11):1642-1643.
|
| 11. |
赫文,徐玉清,王文秀,等.亚砷酸治疗原发性肝癌的临床观察[J].肝脏,2006,11(2):141-142.
|
| 12. |
LIN C C, HSU C, HSU CH, et al. Arsenic trioxide in patients with hepatocellular carcinoma: A phase Ⅱ trial[J]. Invest New Drugs,2007,25(1):77-84.
|
| 13. |
孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:853.
|
| 14. |
周臻涛,林小军,崔伯康,等.含亚砷酸化疗方案TACE治疗中晚期肝癌的临床研究[J].中华肿瘤防治杂志,2007,14(14):1094-1096,1103.
|
| 15. |
华阳,刘德华,李康.肝动脉灌注栓塞联合亚砷酸治疗原发性肝癌的初步探讨[J].中外健康文摘,2007,4(11):13-14.
|
| 16. |
刘院生,赵庆和,王要军.亚砷酸在转移性肝癌介入治疗中的应用[J].现代中西医结合杂志,2007,16(30):4456-4457.
|
| 17. |
钱军,秦叔逵,何泽明,等.三氧化二砷注射液治疗中晚期原发性肝胆癌的临床研究[J].中华肿瘤杂志,2001,23(6):487-489.
|
| 18. |
李江涛,区庆嘉,周修静,等.三氧化二砷治疗肝癌的临床观察(10例报告)[J].现代临床普通外科,2000,5(3):149-150.
|
| 19. |
周锡建,李相勇,范晓强,等.亚砷酸注射液对晚期肝胆肿瘤症状的疗效观察[J].中国医院药学杂志,2006,2(3):320-322.
|
| 20. |
RICHARD D, DINNEN, YIN LI, et al. Synergistic apoptotic death of pancreatic cancer cells using arsenic trioxide and ascorbic acid[J]. AACR Meeting Abstracts,2004,2005,(1):127-b..
|
| 21. |
刘静冰,秦叔逵,钱军,等.三氧化二砷注射液治疗晚期胰腺癌的临床观察[J].临床肿瘤学杂志,2005,10(2):117-119.
|
| 22. |
KINDLER H L, AKLILU M, NATTAM S, et al. Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase Ⅱ trial of the University of Chicago Phase Ⅱ Consortium[J]. Am J Clin Oncol,2008,31(6):553-556.
|
| 23. |
KEVIN B, KIM M D, AGOP Y, et al. A phase Ⅱ trial of arsenic trioxide in patients with metastatic melanoma[J]. Cancer,2005,104(8):1687-1692.
|
| 24. |
TARHINI A A, KIRKWOOD J M, GOODING W E, et al. A phase Ⅱ study of arsenic trioxide (ATO) in patients with metastatic melanoma[J]. J Clin Oncol (Meeting Abstracts),2007,25:8569.
|
| 25. |
POCHI R, SUBBARAYAN A, MAYRA L A, et al. Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: A clinical experience[J]. Acta Oncol,2007,46:557-561.
|
| 26. |
郑作深,饶健.亚砷酸注射液治疗直肠癌术后复发获完全缓解1例[J].临床肿瘤学杂志,2001,6(4):376,381.
|
| 27. |
焦智民,王俊生,杜景富.亚砷酸注射液治疗复发转移的食管癌临床观察[J].中国中西医结合杂志,2002,22(9):713-714.
|
| 28. |
JACQUELINE V, RICHARD Y, LAWRENCE S, et al. Phase Ⅱ trial of arsenic trioxide in patients with metastatic renal cell carcinoma[J]. Invest New Drugs,2002,20:327-330.
|
| 29. |
蒋梅,林丽珠.亚砷酸注射液治疗恶性胸腺瘤获缓解1例[J].临床肿瘤学杂志,2006,11(2):94.
|